Iambic Therapeutics, Inc. Common Stock IAM
$23.81
+25.91%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| 4 | Insider transaction | 2026-10-16 | View → |
| S-1 | S-1 | 2026-09-21 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $23.81
- Market Cap
- —
- 52-Week Range
- $16.15 – $25.00
- Average Volume
- 2.49 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.